Zwischen 1980 und 1984 wurden 54 Patientinnen mit fortgeschrittenem Ovarialkarzinom, die nach Operation und anschließender Chemotherapie mit Alkeran (n = 7) oder Cis-Platin/Alkeran ± Hexa-methylmelamin (n = 47) sowie Second-look-Laparotomie behandelt worden waren, entweder mit der Moving-strip-Technik (n = 35) oder später mit der Open-field-Technik (n = 19) nachbestrahlt. 32 Patientinnen kamen in CR zur Nachbestrahlung. 15 CR-Patientinnen waren nach Open-field-Bestrahlung und mittlerer Beobachtungszeit von 25 Monaten rezidivfrei. Zu diesem Zeitpunkt hatten von 17 Patientinnen mit Moving-strip-Bestrahlung 5 Rezidive. Die Rezidivhäufigkeit geht offenbar zu Lasten der sehr langen Bestrahlungszeit und häufiger Therapieunterbrechung. Waren zum Bestrahlungsbeginn Resttumoren vorhanden, konnte durch eine Strahlentherapie eine CR nur dann erreicht werden, wenn lediglich eine Alkeran-Monotherapie vorangegangen war.

This content is only available via PDF.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.